Provectus Pharmaceuticals

About:

Provectus Pharmaceuticals develops advanced therapies that destroy cancers such as melanoma, liver, and breast cancer.

Website: http://pvct.com

Description:

Provectus Pharmaceuticals focuses on creating sophisticated medicines to target and eliminate the most lethal cancers. Provectus also creates ground-breaking biotechnologies to improve vaccine production and detect viruses. It develops and markets innovative over-the-counter skin care products, as well as licensing unique technologies for therapeutic and cosmetic medical devices.

Total Funding Amount:

$10.6M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Knoxville, Tennessee, United States

Founded Date:

1978-05-01

Contact Email:

info(AT)pvct.com

Founders:

Craig Dees

Number of Employees:

51-100

Last Funding Date:

2014-04-17

IPO Status:

Public

Industries:

© 2025 bioDAO.ai